## 13/09/2025

### Key Findings:

**1. Acute Hepatic Crisis (September 12, 2025)**
Your most recent blood work shows a dramatic deterioration in liver function markers, with what appears to be a severe hepatobiliary crisis. This coincides precisely with your reported symptoms of fatigue, inflammation, excessive urination, and diarrhea.

**2. Cholestatic Pattern**
The elevation pattern suggests cholestatic injury (bile duct inflammation/obstruction) rather than pure hepatocellular damage, which is consistent with PSC exacerbation. The disproportionate rise in alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) compared to transaminases is classic for biliary tract pathology.

**3. Post-Infectious Complications**
The timeline is critical here:
- **August 5-14**: Cholangitis hospitalization (bacterial infection of bile ducts)
- **August 31**: C. difficile infection with UC flare
- **September 12**: Acute decompensation

This sequence suggests you may be experiencing:
- Recurrent cholangitis or incomplete resolution of the initial infection
- PSC stricture progression triggered by recent infections
- Post-infectious inflammatory response affecting both IBD and PSC

### Possible Explanations:

1. **Recurrent Ascending Cholangitis**: The sudden enzyme elevation with systemic symptoms strongly suggests another episode of cholangitis, possibly due to bacterial seeding during your recent infections.

2. **Dominant Stricture Development**: PSC can develop dominant strictures that cause acute obstruction, leading to the dramatic enzyme elevations you're experiencing.

3. **Drug-Induced Hepatotoxicity**: If you received antibiotics for C. diff (likely vancomycin or fidaxomicin), there could be a component of medication-related liver injury, though this seems less likely given the cholestatic pattern.

4. **Overlap Syndrome Flare**: The combination of UC flare and PSC exacerbation can create a severe inflammatory cascade affecting multiple organ systems.

### Prognosis and Recommendations:

**Immediate Concerns:**
- The multi-fold increase in liver enzymes with systemic symptoms suggests active biliary sepsis or severe cholestasis requiring urgent intervention
- The fluid shifts (edema followed by diuresis) suggest possible hepatic decompensation

**Short-term Prognosis:**
With appropriate treatment, acute cholangitis typically responds well to antibiotics and biliary drainage if needed. However, given your recent infection history, you may need:
- Extended antibiotic therapy
- MRCP or ERCP to evaluate for dominant strictures
- Possible biliary intervention (stenting/dilation)

**Long-term Considerations:**
- Recurrent cholangitis episodes accelerate PSC progression
- Your young age at diagnosis (20) and now 20 years of disease duration puts you at higher risk for cirrhosis and need for transplant evaluation
- The recent pattern of infections suggests your disease may be entering a more aggressive phase

**URGENT: You should seek immediate medical evaluation, preferably at a center with hepatology expertise. The combination of markedly elevated liver enzymes, systemic symptoms, and your PSC history warrants urgent assessment for cholangitis and possible biliary intervention.**

## 16/09/25

### üîé Tend√™ncias atuais dos seus exames

1. **Inflama√ß√£o (PCR / Prote√≠na C Reativa):**

   * Subiu com a infec√ß√£o/flare, mas vem caindo aos poucos de picos (\~8‚Äì9 mg/dL) para cerca de **6,3 mg/dL** em 16/09.
   * Indica que **a inflama√ß√£o ainda existe, mas est√° diminuindo**.

2. **Leuc√≥citos:**

   * Estavam elevados (>15 mil) durante a infec√ß√£o.
   * Agora ca√≠ram para **\~9,7 mil** em 16/09, perto da faixa normal.
   * Sugere **melhora da atividade infecciosa/inflamat√≥ria**.

3. **Plaquetas:**

   * Subiram de \~410 mil ‚Üí quase **490 mil**.
   * Isso √© comum em **inflama√ß√£o persistente ou estresse hep√°tico** (trombocitose reativa).
   * N√£o preocupa isoladamente, mas mostra que o organismo ainda est√° em estado pr√≥-inflamat√≥rio.

4. **Enzimas hep√°ticas:**

   * **AST (TGO), ALT (TGP), GGT e Fosfatase Alcalina** tiveram eleva√ß√£o acentuada no epis√≥dio de colestase.
   * Agora parecem **estabilizadas ou em leve queda**, em linha com a resson√¢ncia (sem colangite aguda).
   * O Tozacin pode estar ajudando a prevenir infec√ß√£o secund√°ria, enquanto a pr√≥pria PSC mant√©m as enzimas altas.

5. **Bilirrubina:**

   * Est√° elevada, mas **sem piora recente**.
   * Bilirrubina est√°vel + PCR em queda √© sinal de que n√£o h√° piora obstrutiva/infecciosa no momento.

### üìà Interpreta√ß√£o cl√≠nica

* A **infec√ß√£o por C. difficile** (in√≠cio de setembro) desencadeou inflama√ß√£o sist√™mica e provavelmente precipitou o **flare da RCU**.
* A **PSC** complicou o quadro: as enzimas subiram, mas a resson√¢ncia afastou nova obstru√ß√£o.
* Os m√©dicos entraram com **antibi√≥tico de amplo espectro (Tozacin)** para proteger contra colangite bacteriana ‚Äî conduta razo√°vel considerando seu hist√≥rico (colangite aguda no in√≠cio de agosto).
* Agora, os exames sugerem:

  * Infec√ß√£o sob controle (queda de leuc√≥citos e PCR).
  * Colite ulcerativa ainda ativa, mas melhorando.
  * PSC est√°vel, sem sinais de piora aguda.


### ‚è≥ Linha do tempo de recupera√ß√£o (t√≠pico, baseado nos seus dados)

* **Nesta semana:** PCR e leuc√≥citos devem se aproximar da normalidade se a infec√ß√£o estiver realmente controlada.
* **1‚Äì2 semanas:** Enzimas hep√°ticas podem continuar altas, mas devem cair gradualmente se n√£o houver nova colangite.
* **Colite ulcerativa:** a melhora pode demorar mais (algumas semanas), especialmente se houver ajuste de corticoide/biol√≥gicos.
* **PSC:** risco cr√¥nico ‚Äî objetivo √© estabilizar, n√£o normalizar completamente.

### ‚ö†Ô∏è O que ainda pode acontecer

* Se enzimas hep√°ticas subirem novamente + febre ‚Üí suspeita de **nova colangite**.
* Se PCR n√£o cair ou plaquetas continuarem subindo ‚Üí pode indicar **inflama√ß√£o cont√≠nua ou complica√ß√£o secund√°ria**.
* Se bilirrubina aumentar muito ‚Üí pode haver **nova obstru√ß√£o ou evento biliar**.


‚úÖ **Resumo:**
Voc√™ est√° na **fase de melhora da tempestade inflamat√≥ria/infecciosa**: a C. diff e o flare da colite desencadearam o quadro, mas os antibi√≥ticos e o suporte hospitalar estabilizaram. A expectativa √© de **melhora lenta e progressiva nas pr√≥ximas 1‚Äì2 semanas**, desde que n√£o ocorra nova colangite ou reativa√ß√£o da RCU.

